Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. (AHR) is poised for substantial growth, particularly through its Integrated Senior Health Campuses segment, which has demonstrated strong cash net operating income (NOI) growth and is expected to achieve a two-year compound annual growth rate (CAGR) of 11.8%. The company's recent improvements in its cost of capital position, alongside active investment strategies, suggest that AHR may successfully deploy capital in a manner that enhances overall returns. Additionally, the operational efficiencies expected from Trilogy, alongside favorable industry trends, could lead to improved Medicare Advantage reimbursement rates and further strengthen AHR's financial performance.

Bears say

American Healthcare REIT Inc faces multiple risks that contribute to a negative outlook on its stock, particularly due to its reliance on its Integrated Senior Health Campuses segment for revenue generation. Economic headwinds or changes in regulatory conditions affecting tenants may lead to lower Medicaid rates and hinder the company's ability to achieve expected organic NOI growth, posing further risks to earnings performance. Additionally, the REIT's significant exposure to skilled nursing facilities, which represent a substantial portion of its net operating income, increases vulnerability to operational volatility and external pressures in the healthcare market.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $52.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $52.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.